Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer

基质 队列 卵巢癌 肿瘤科 组织微阵列 癌症 内科学 浆液性癌 生物标志物 医学 比例危险模型 无进展生存期 队列研究 化疗 病理 生物 免疫组织化学 生物化学
作者
Emil Lou,Valentino Clemente,Marcel Grube,Axel Svedbom,Andrew C. Nelson,Freya Blome,Annette Staebler,Stefan Kommoss,Martina Bazzaro
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (2): e240407-e240407 被引量:5
标识
DOI:10.1001/jamanetworkopen.2024.0407
摘要

IMPORTANCE Platinum-based chemotherapy is the backbone of standard-of-care treatment for patients with advanced-stage, high-grade serous carcinoma (HGSC), the most common form of ovarian cancer; however, one-third of patients have or acquire chemoresistance toward platinum-based therapies. OBJECTIVE To demonstrate the utility of tumor-stroma proportion (TSP) as a predictive biomarker of chemoresistance of HGSC, progression-free survival (PFS), and overall survival (OS). DESIGN, SETTING, AND PARTICIPANTS This prognostic study leveraged tumors from patients with HGSC in The Cancer Genome Atlas (TCGA) cohort (1993-2013) and an independent cohort of resected clinical specimens from patients with HGSC (2004-2014) available in diagnostic and tissue microarray formats from the University of Tübingen in Germany. Data analysis was conducted from January 2021 to January 2024. EXPOSURE Diagnosis of HGSC. MAIN OUTCOMES AND MEASURES Principal outcome measures were the ability of TSP to predict platinum chemoresistance, PFS, and OS. Using hematoxylin and eosin–stained slides from the Tübingen cohort (used for routine diagnostic assessment from surgical specimens) as well as tissue microarrays, representative sections of tumors for scoring of TSP were identified using previously evaluated cutoffs of 50% stroma or greater (high TSP) and less than 50% stroma (low TSP). Digitized slides from the TCGA Cohort were analyzed and scored in a similar fashion. Kaplan-Meier time-to-event functions were fit to estimate PFS and OS. RESULTS The study included 103 patients (mean [SD] age, 61.6 [11.1] years) from the TCGA cohort and 192 patients (mean [SD] age at diagnosis, 63.7 [11.1] years) from the Tübingen cohort. In the TCGA cohort, there was no significant association of TSP levels with chemoresistance, PFS, or OS. However, in the Tübingen cohort, high TSP was associated with significantly shorter PFS (HR, 1.586; 95% CI, 1.093-2.302; P = .02) and OS (hazard ratio [HR], 1.867; 1.249-2.789; P = .002). Patients with chemoresistant tumors were twice as likely to have high TSP as compared to patients with chemosensitive tumors (HR, 2.861; 95% CI, 1.256-6.515; P = .01). In tissue microarrays from 185 patients from the Tübingen cohort, high TSP was again associated with significantly shorter PFS (HR, 1.675; 95% CI, 1.012-2.772 P = .04) and OS (HR, 2.491; 95% CI, 1.585-3.912; P < .001). CONCLUSIONS AND RELEVANCE In this prognostic study, TSP was a consistent and reproducible marker of clinical outcome measures of HGSC, including PFS, OS, and platinum chemoresistance. Accurate and cost-effective predictive biomarkers of platinum chemotherapy resistance are needed to identify patients most likely to benefit from standard treatments, and TSP can easily be implemented and integrated into prospective clinical trial design and adapted to identify patients who are least likely to benefit long-term from conventional platinum-based cytotoxic chemotherapy treatment at the time of initial diagnosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xcgh的应助被甜美柏柳采纳,获得10
刚刚
WU完成签到,获得积分10
刚刚
hhh2018687完成签到,获得积分10
刚刚
seeker完成签到,获得积分20
刚刚
Acer完成签到 ,获得积分10
1秒前
YX完成签到,获得积分10
1秒前
爱学习的楠完成签到,获得积分10
1秒前
2秒前
Hindiii完成签到,获得积分0
2秒前
洋芋二号发布了新的文献求助10
3秒前
cola完成签到,获得积分10
3秒前
淡定的白山完成签到,获得积分10
3秒前
害怕的路灯完成签到,获得积分10
3秒前
忧心的峻熙完成签到,获得积分10
3秒前
3秒前
Jimmy完成签到,获得积分10
3秒前
尹容易完成签到,获得积分10
3秒前
曾业辉发布了新的文献求助10
3秒前
粥游天下完成签到,获得积分10
3秒前
研友_LwlRen完成签到 ,获得积分10
3秒前
3秒前
木子木公完成签到,获得积分10
4秒前
栀盎完成签到 ,获得积分10
4秒前
4秒前
skiboy完成签到,获得积分10
5秒前
科研通AI6.2的应助被BAEKHYUNLUCKY采纳,获得10
5秒前
穆仰完成签到,获得积分10
5秒前
清爽映冬发布了新的文献求助10
5秒前
龙溪完成签到,获得积分10
5秒前
小蘑菇的应助被羊翊婕采纳,获得10
5秒前
詹慧子完成签到,获得积分10
6秒前
sonjsnd完成签到,获得积分10
6秒前
6秒前
枫叶完成签到,获得积分10
6秒前
火星上翠桃完成签到 ,获得积分10
7秒前
喵喵不二完成签到 ,获得积分10
7秒前
FBH一号机完成签到,获得积分10
8秒前
lilyz615完成签到,获得积分10
8秒前
li完成签到,获得积分10
8秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152197
求助须知:如何正确求助?哪些是违规求助? 9548983
关于积分的说明 21689256
捐赠科研通 7740443
什么是DOI,文献DOI怎么找? 3425145
关于科研通互助平台的介绍 2550358
邀请新用户注册赠送积分活动 2468604